35 results
Page 2 of 2
10-K
rdropjphsu
29 Mar 22
Annual report
4:20pm
8-K
EX-99.1
sxmh5joa2f5
29 Mar 22
Lyell Immunopharma Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
4:15pm
8-K
EX-99.2
qx0q2k 6m
17 Dec 21
Lyell Immunopharma Announces cGMP Qualification of LyFE™ Manufacturing Center in Advance of Initiating Clinical Programs
4:02pm
8-K
js87px6 3rs6h
17 Dec 21
Lyell Immunopharma Announces cGMP Qualification of LyFE™ Manufacturing Center in Advance of Initiating Clinical Programs
4:02pm
8-K
EX-99.1
ki3lqw12cz7 nwit1
17 Dec 21
Lyell Immunopharma Announces cGMP Qualification of LyFE™ Manufacturing Center in Advance of Initiating Clinical Programs
4:02pm
8-K
EX-99.1
a521v 83uj2ht2
12 Nov 21
Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights
8:20am
10-Q
fnc0 q8dts2m06
12 Aug 21
Quarterly report
5:07pm
8-K
EX-99.1
m00e23y2jm4s
12 Aug 21
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
4:18pm
424B4
32191ce gjtz190bo12
18 Jun 21
Prospectus supplement with pricing info
12:00am
S-1/A
z2cgdj91hz8jssan
9 Jun 21
IPO registration (amended)
7:12am
CORRESP
g961 j2o81ffkk
28 May 21
Correspondence with SEC
12:00am
S-1
iuaegg35r 1wtpv
25 May 21
IPO registration
5:28pm
DRS/A
0u8x9voku9xn0pr035r
12 May 21
Draft registration statement (amended)
12:00am
DRS
saksgazf6hp4
12 Apr 21
Draft registration statement
12:00am